Cardiac Biomarkers and the Diagnosis of Myocardial Infarction in Women
- PMID: 28391559
- PMCID: PMC5385194
- DOI: 10.1007/s11886-017-0839-9
Cardiac Biomarkers and the Diagnosis of Myocardial Infarction in Women
Abstract
Purpose of review: Women with suspected acute coronary syndrome are less likely to undergo investigation or receive treatment than men, and women consistently have poorer outcomes. This review summarises how the latest development in cardiac biomarkers could improve both diagnosis and outcomes in women.
Recent findings: Novel high-sensitivity cardiac troponin assays have identified differences in the reference range and therefore diagnostic threshold for myocardial infarction in men and women. These differences are present across multiple populations with different ethnic backgrounds and for a range of assays. The use of a uniform threshold for cardiac troponin does not provide equivalent prediction in men and women, with lower thresholds needed for women to provide comparable risk stratification. Sex differences in cardiac troponin concentrations are not widely recognised in clinical practice and may be contributing to the under-diagnosis of myocardial infarction in women and discrepancies in patient care and outcomes.
Keywords: Biomarkers; Cardiac troponin; Myocardial infarction; Sex.
Conflict of interest statement
Conflict of Interest
Anoop S.V. Shah has received honoraria from Abbott Diagnostics. Amy V. Ferry declares that she has no conflict of interest. Nicholas L. Mills has consulted and received research grants from Abbott Diagnostics and has consulted for Roche Diagnostics and Singulex.
Human and Animal Rights and Informed Consent
All studies included in this review were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Figures


References
-
- Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128. doi: 10.1016/S0140-6736(12)61728-0. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials